Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 21, 2025
Tiziana announced a product development services agreement with Renaissance Lakewood LLC. This collaboration aims to optimize the current formulation and develop a comprehensive plan for the scale-up of foralumab in a nasal device. Intranasal ...
read more
Dr. Reddy’s announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose Vials, the generic equivalent of Geodon.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Mylan has announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta® Tablets.
read more
Arch Biopartners has hired Dalton Pharma Services to perform the good manufacturing practice campaign for Metablok, the company's drug candidate for preventing acute kidney injury.
read more
Sharps Compliance announced the appointment of Adrian W. Burke as Senior Vice President of Operations.
read more
Friday, November 20, 2015
Elixirgen, LLC, a growing biotechnology company in Baltimore, has entered an exclusive license agreement with Sumitomo Dainippon Pharma Co., Ltd., a major pharmaceutical company in Japan.
read more
Novartis is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell ...
read more
Catalent Pharma Solutions has completed a $5.5 million expansion program at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.
read more
ProteoGenix , Aseem Healthcare, and Trident Biopharm Solutions announced the development of a new antibody cocktail effective against major variants of SARS-CoV-2. The cocktail of four fully human neutralizing antibodies (AH-5-COV) was generated by ...
read more
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced that Matti Masanovich has been named Senior Vice President & Chief Financial Officer, effective July 5, 2023.
read more
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Friday, December 01, 2017
Astellas Pharma and Mitobridge announced Astellas has exercised its exclusive option right to acquire Mitobridge under the amended terms of the October 2013 partnership agreement.
read more
Roambee, the Silicon Valley-headquartered global supply chain visibility provider announces its second acquisition, Modum, a European pharma last mile-focused cold chain monitoring player based in Zurich, Switzerland. This acquisition will enable ...
read more
Wednesday, November 14, 2018
A Federal District Court jury yesterday found that 10X Genomics willfully infringed three United States patents owned by the University of Chicago and exclusively licensed to Bio-Rad Laboratories.
read more